7459 — Medipal Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapSuper Stock

Annual income statement for Medipal Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,253,079	3,211,125	3,290,921	3,360,008	3,558,732
Cost of Revenue
Gross Profit	236,697	214,213	217,445	224,305	246,655
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,202,030	3,187,304	3,250,430	3,318,994	3,509,827
Operating Profit	51,049	23,821	40,491	41,014	48,905
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	75,536	49,237	57,284	70,061	74,741
Provision for Income Taxes
Net Income After Taxes	51,230	33,616	39,197	48,323	51,768
Minority Interest
Net Income Before Extraordinary Items
Net Income	37,970	23,927	29,425	38,806	41,475
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	37,865	23,823	29,320	38,752	41,474
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	147	152	148	206	196
Dividends per Share